CliffBio
small molecule

PIXXOSCAN

GADOBUTROL

Loss of exclusivity—loss of exclusivity
CompanyGE HEALTHCARE INC

Drug detail

Brand namePIXXOSCAN
Active ingredientGADOBUTROL
Strength4.5354GM/7.5ML (604.72MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2026
Marketing statusRX

More from GE HEALTHCARE INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.